Overall survival rates of 200 patients with non-Hodgkin lymphoma by the International Prognostic Index and the pretreatment S-VEGF and S-bFGF.

The cut-off values used are greater than or equal to 2 adverse features by the IPI and the highest quartiles for S-VEGF and S-bFGF (462 pg/mL or more and 5.5 pg/mL or more, respectively). Survival rates at 24 and 60 months are given. The plotted cumulative survival lines from the top are: (1) less than 2 adverse features by the IPI, and S-VEGF and S-bFGF less than the highest quartiles; (2) less than 2 adverse features by the IPI, and S-VEGF and S-bFGF greater than or equal to the highest quartiles; (3) greater than or equal to 2 adverse features by the IPI and S-VEGF, and S-bFGF less than the highest quartiles; (4) greater than or equal to 2 adverse features by the IPI and S-VEGF, and S-bFGF greater than or equal to the highest quartiles.